Hexima Limited (HXL.AX)

AUD 0.01

(0.0%)

Total Assets Summary of Hexima Limited

  • Hexima Limited's latest annual total assets in 2024 was 2.26 Million AUD , down -23.26% from previous year.
  • Hexima Limited's latest quarterly total assets in 2024 FY was 2.26 Million AUD , down -23.26% from previous quarter.
  • Hexima Limited reported annual total assets of 2.95 Million AUD in 2023, down -72.51% from previous year.
  • Hexima Limited reported annual total assets of 10.75 Million AUD in 2022, up 25.41% from previous year.
  • Hexima Limited reported quarterly total assets of 2.26 Million AUD for 2024 FY, down -23.26% from previous quarter.
  • Hexima Limited reported quarterly total assets of 2.26 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Hexima Limited (2024 - 2008)

Historical Annual Total Assets of Hexima Limited (2024 - 2008)

Year Total Assets Total Assets Growth
2024 2.26 Million AUD -23.26%
2023 2.95 Million AUD -72.51%
2022 10.75 Million AUD 25.41%
2021 8.57 Million AUD -32.51%
2020 12.7 Million AUD 120.94%
2019 5.75 Million AUD -12.73%
2018 6.58 Million AUD -20.69%
2017 8.3 Million AUD 20.25%
2016 6.9 Million AUD -20.01%
2015 8.63 Million AUD -20.08%
2014 10.8 Million AUD -15.21%
2013 12.74 Million AUD 0.0%
2010 26.07 Million AUD -17.0%
2009 31.41 Million AUD -14.31%
2008 36.66 Million AUD 0.0%

Peer Total Assets Comparison of Hexima Limited

Name Total Assets Total Assets Difference
AdAlta Limited 5.57 Million AUD 59.286%
Acrux Limited 8.96 Million AUD 74.685%
Race Oncology Limited 20.22 Million AUD 88.783%
Biome Australia Limited 8.27 Million AUD 72.586%
Botanix Pharmaceuticals Limited 112.46 Million AUD 97.982%
BTC Health Limited 5.14 Million AUD 55.931%
Chimeric Therapeutics Limited 15.27 Million AUD 85.144%
CSL Limited 56.93 Billion AUD 99.996%
Clarity Pharmaceuticals Ltd 154.62 Million AUD 98.533%
Clinuvel Pharmaceuticals Limited 231.12 Million AUD 99.018%
EZZ Life Science Holdings Limited 25.55 Million AUD 91.12%
Immutep Limited 147.44 Million AUD 98.461%
Memphasys Limited 12.43 Million AUD 81.746%
Neuren Pharmaceuticals Limited 247.97 Million AUD 99.085%
Noxopharm Limited 6.78 Million AUD 66.552%
Prescient Therapeutics Limited 20.39 Million AUD 88.874%
Radiopharm Theranostics Limited 72.03 Million AUD 96.85%
Starpharma Holdings Limited 36.81 Million AUD 93.837%
Tissue Repair Ltd 19.38 Million AUD 88.298%
Biotron Limited 493.47 Thousand AUD -359.8%
Alterity Therapeutics Limited 19.22 Million AUD 88.197%
Anatara Lifesciences Ltd 1.67 Million AUD -35.753%
Bio-Gene Technology Limited 3.15 Million AUD 28.187%
Zelira Therapeutics Limited 5.18 Million AUD 56.226%
Patrys Limited 4.16 Million AUD 45.477%
Orthocell Limited 26.61 Million AUD 91.475%
Imugene Limited 151.39 Million AUD 98.501%
PYC Therapeutics Limited 91.23 Million AUD 97.513%
Proteomics International Laboratories Limited 10.87 Million AUD 79.136%
Cynata Therapeutics Limited 8.38 Million AUD 72.95%
Arovella Therapeutics Limited 13.28 Million AUD 82.92%
Nanollose Limited 241.95 Thousand AUD -837.795%
Invex Therapeutics Ltd 6.12 Million AUD 62.925%
NeuroScientific Biopharmaceuticals Limited 5.43 Million AUD 58.259%
Amplia Therapeutics Limited 14.84 Million AUD 84.715%
Island Pharmaceuticals Limited 2.56 Million AUD 11.522%
Nyrada Inc. 5.9 Million AUD 61.59%
Telix Pharmaceuticals Limited 398.3 Million AUD 99.43%
Dimerix Limited 32.07 Million AUD 92.927%
PharmAust Limited 11.12 Million AUD 79.604%
AnteoTech Limited 9.38 Million AUD 75.813%
Paradigm Biopharmaceuticals Limited 27.39 Million AUD 91.716%
Recce Pharmaceuticals Ltd 6.36 Million AUD 64.378%
Avecho Biotechnology Limited 7.31 Million AUD 69.0%
Actinogen Medical Limited 21.31 Million AUD 89.353%
Immuron Limited 15.54 Million AUD 85.408%
Argenica Therapeutics Limited 16.37 Million AUD 86.146%